Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.53B | $62.75B | $61.86B | $60.53B | $57.35B | $55.18B | $57.71B | $79.59B | $79.14B | $79.92B | $81.74B | $92.79B | $98.37B | $102.87B | $106.92B | $99.87B | $95.76B | $103.63B | $98.79B |
| Gross profit | $39.30B | $35.55B | $34.30B | $32.69B | $31.49B | $30.86B | $31.53B | $36.94B | $36.94B | $38.52B | $40.68B | $46.41B | $48.68B | $50.36B | $50.14B | $46.01B | $43.78B | $45.66B | $41.73B |
| Gross margin | 58.19% | 56.65% | 55.45% | 54.00% | 54.90% | 55.94% | 54.64% | 46.41% | 46.68% | 48.19% | 49.77% | 50.01% | 49.49% | 48.95% | 46.89% | 46.07% | 45.72% | 44.06% | 42.24% |
| Research & development | $8.32B | $7.48B | $6.78B | $6.57B | $6.49B | $6.26B | $5.91B | $5.38B | $5.59B | $5.73B | $5.25B | $5.44B | $5.74B | $5.82B | $6.26B | $6.03B | $5.82B | $6.34B | $6.15B |
| Operating expenses | $26.80B | $25.48B | $24.92B | $24.51B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $12.49B | $10.07B | $9.38B | $8.17B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 18.50% | 16.05% | 15.17% | 13.50% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $17.28B | $12.18B | $14.69B | $7.17B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA margin | 25.59% | 19.40% | 23.75% | 11.85% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | $10.59B | $6.02B | $7.50B | $1.64B | $5.74B | $5.59B | $9.43B | $8.73B | $5.75B | $11.87B | $13.19B | $12.02B | $16.48B | $16.60B | $15.86B | $14.83B | $13.43B | $12.33B | $10.42B |
| Net profit margin | 15.69% | 9.60% | 12.13% | 2.71% | 10.01% | 10.13% | 16.34% | 10.97% | 7.27% | 14.86% | 16.14% | 12.96% | 16.76% | 16.14% | 14.83% | 14.85% | 14.02% | 11.90% | 10.55% |
| Basic EPSper basic share | $11.36 | $6.53 | $8.23 | $1.82 | $6.41 | $6.28 | $10.63 | $9.57 | $6.17 | $12.43 | $13.48 | $11.97 | $15.06 | $14.53 | $13.25 | $11.69 | $10.12 | $9.02 | $7.27 |
| Diluted EPSper diluted share | $11.17 | $6.43 | $8.14 | $1.80 | $6.35 | $6.23 | $10.56 | $9.52 | $6.14 | $12.38 | $13.42 | $11.90 | $14.94 | $14.37 | $13.06 | $11.52 | $10.01 | $8.89 | $7.15 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 25, 2026Form 4 | Miebach MichaelDirector | BuyCommon Stock | 434 | $233.33 | $101.3K | 434 |
| Feb 25, 2026Form 4 | HOWARD MICHELLE JDirector | BuyCommon Stock | 50 | $237.83 | $11.9K | 194 |
| Jan 30, 2026Form 4 | FARR DAVID NDirector | BuyCommon Stock | 1.0K | $304.00 | $304.0K | 9.3K |
| Mar 3, 2025Form 4 | Thomas Robert DavidSenior Vice President | SellCommon Stock | 26.5K | $253.01 | $6.72M | 45.0K |
| Feb 28, 2025Form 4 | FARR DAVID NDirector | BuyCommon Stock | 1.2K | $249.00 | $298.8K | 8.3K |
IBM ($IBM) and Lockheed Martin ($LMT) established a quantum-innovation hub at ETH Zurich through an offset agreement with Switzerland’s defense-procurement agency, armasuisse. The hub plans to host Switzerland’s first IBM Quantum System Two ...